ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Therapeutic nucleus-access BNCT drug combined CD47-targeting gene editing in glioblastoma

Chen, Jiejian; Dai, Qi; Yang, QiYao; Bao, Xiaoyan; Zhou, Yi; Zhong, Haiqing; Wu, Linjie; Wang, Tiantian; Zhang, Zhicheng; Lu, Yiying; Zhang, Zhentao; Lin, Mengting; Han, Min*; Wei, Qichun*浙江大学
JOURNAL OF NANOBIOTECHNOLOGY2022-3-4DOI: 10.1186/s12951-022-01304-0
24被引7阅读
引用收藏
分享

摘要

Glioblastoma is the most common brain primary malignant tumor with the highest mortality. Boron neutron capture therapy (BNCT) can efficiently kill cancer cells on the cellular scale, with high accuracy, short course and low side-effects, which is regarded as the most promising therapy for malignant brain tumors like glioma. As the keypoint of BNCT, all boron delivery agents currently in clinical use are beset by insufficient tumor uptake, especially in the tumor nucleus, which limits the clinical application of BNCT. In this study, nuclear targeting of boron is achieved by DOX-CB, consisting of doxorubicin (DOX) and carborane (CB) utilizing the nuclear translocation property of DOX. The nucleus of GL261 cells takes up almost three times the concentration of boron required for BNCT. To further kill glioma and inhibit recurrence, a new multifunctional nanoliposome delivery system DOX-CB@lipo-pDNA-iRGD is constructed. It combines DOX-CB with immunotherapy strategy of blocking macrophage immune checkpoint pathway CD47-SIRP alpha by CRISPR-Cas9 system, coupling BNCT with immunotherapy simultaneously. Compared with clinical drug Borocaptate Sodium (BSH), DOX-CB@lipo-pDNA-iRGD significantly enhances the survival rate of tumor-bearing mice, reduces tumor stemness, and improves the prognosis. The excellent curative effect of this nanoliposome delivery system provides an insight into the combined treatment of BNCT.

学科与关键词

关键词
Boron neutron capture therapyBoron agentNanoliposomeNucleus-targetingGliomaCD47
相关
加载中…
  • Polyhedral Oligomeric Silsesquioxane-Based Nanoparticles for Efficient Chemotherapy of Glioblastoma
    Zhong, Xiangyang; Wei, Gang; Liu, Boyang; Wang, Chenyang; Wang, Juan; Lu, Yong*; Cui, Wenguo*; Guo, Hongbo*Small, 2023, 19(18).被引 3
  • Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy
    Xiang, Jing; Ma, Lin; Tong, Jianfei; Zuo, Nan; Hu, Weitao; Luo, Yupeng; Liu, Junqi; Liang, Tianjiao; Ren, Qiushi*; Liu, Qi*Frontiers in Medicine, 2023, 10: 1199881.
  • Glioma cell membrane camouflaged cinobufotalin delivery system for combinatorial orthotopic glioblastoma therapy
    Song, Zibin; Zhao, Liqian; Fang, Weiyi; Guo, Siyun; Xu, Anqi; Zhan, Zhengming; Cai, Yonghua; Xue, ShuaiShuai; Chai, Peng; Jiang, Qiuhua*; Zhao, Peng*; Song, Ye*Nano Research, 2023, 16(8): 11164-11175.
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF NANOBIOTECHNOLOGY
发表日期
2022-03-04
卷期
第 20 卷, 第 1 期
页码
102
DOI
10.1186/s12951-022-01304-0
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81673022, 82073332, 81572952]

作者

  • C

    Chen, Jiejian (第一作者)

    2 · zhejiang univ

  • D

    Dai, Qi

    2 · zhejiang univ

查看全部 14 位作者收起作者
  • Y

    Yang, QiYao

    2 · zhejiang univ

  • B

    Bao, Xiaoyan

    zhejiang univ

  • Z

    Zhou, Yi

    zhejiang univ

  • Z

    Zhong, Haiqing

    zhejiang univ

  • W

    Wu, Linjie

    zhejiang univ

  • W

    Wang, Tiantian

    zhejiang univ

  • Z

    Zhang, Zhicheng

    2 · zhejiang univ

  • L

    Lu, Yiying

    zhejiang univ

  • Z

    Zhang, Zhentao

    zhejiang univ

  • L

    Lin, Mengting

    zhejiang univ

  • H

    Han, Min (通讯)

    zhejiang univ

  • W

    Wei, Qichun (通讯)

    2 · zhejiang univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417